September 28, 2021 — CenTrak, Inc. and Sonitor Technologies, Inc. announced today that they have settled all claims between them in their litigation pending in the United State District Court for the District of Delaware. The terms of the settlement are confidential, but the parties report that their agreement frees each company’s products from claims of patent infringement and resolves all disputes between them.
CenTrak is a subsidiary of Halma plc, a London Stock Exchange listed company. CenTrak empowers healthcare leaders with actionable data to increase productivity, reduce operating costs, and transform patient care via market-leading locating and sensing IoT solutions. Founded in 2007, CenTrak is trusted by more than 2,000 healthcare organizations around the world.
Sonitor Technologies is a subsidiary of Sonitor IPS Holding. For over 20 years the company has led in developing and commercializing ultrasound-based RTLS (Real-Time Location Systems) for healthcare and other market segments.
Sonitor’s patented ultrasound technology continues to set the standard for accurate indoor positioning. Sonitor Sense™ has established itself as the RTLS market leader in accurate and reliable indoor positioning in hospitals, clinics, and long- term care facilities worldwide.